STATE STREET CORP - LIXTE BIOTECHNOLOGY HLDGS IN ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of LIXTE BIOTECHNOLOGY HLDGS IN
ValueSharesWeighting
Q1 2023$29,843
-18.2%
35,956
-50.0%
0.00%
Q4 2022$36,496
+82.5%
71,912
+100.0%
0.00%
Q3 2022$20,000
-28.6%
35,9560.0%0.00%
Q2 2022$28,000
-34.9%
35,956
+1.3%
0.00%
Q1 2022$43,000
+2.4%
35,5000.0%0.00%
Q4 2021$42,000
-40.0%
35,500
+5.7%
0.00%
Q3 2021$70,000
-31.4%
33,6000.0%0.00%
Q2 2021$102,00033,6000.00%
Other shareholders
LIXTE BIOTECHNOLOGY HLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 99,644$56,0000.07%
SANTA MONICA PARTNERS LP 166,667$93,0000.07%
Virtu Financial LLC 12,784$7,0000.00%
Warberg Asset Management LLC 14,500$8,0000.00%
TWO SIGMA INVESTMENTS, LP 21,274$12,0000.00%
FMR LLC 100$00.00%
WELLS FARGO & COMPANY/MN 51$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 25,794$14,0000.00%
STATE STREET CORP 35,956$20,0000.00%
View complete list of LIXTE BIOTECHNOLOGY HLDGS IN shareholders